Moragas N, Fernandez-Nogueira P, Recalde-Percaz L, Inman JL, López-Plana A, Bergholtz H, Noguera-Castells A, Del Burgo PJ, Chen X, Sorlie T, Gascón P, Bragado P, Bissell M, Carbó N, Fuster G(2024) The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma Breast Cancer Res, 26(1), 122 DOI 10.1186/s13058-024-01871-0, PubMed 39138514
Cun HT, Bernard L, Lande KT, Lawson BC, Nesbakken AJ, Davidson B, Lindemann K, Fellman B, Sørlie T, Soliman PT, Eriksson AGZ(2024) Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma Gynecol Oncol, 189, 138-145(in press) DOI 10.1016/j.ygyno.2024.07.677, PubMed 39126895
Ohnstad HO, Blix ES, Akslen LA, Gilje B, Raj SX, Skjerven H, Borgen E, Janssen EAM, Mortensen E, Brekke MB, Falk RS, Schlichting E, Boge B, Songe-Møller S, Olsson P, Heie A, Mannsåker B, Vestlid MA, Kursetgjerde T, Gravdehaug B, Suhrke P, Sanchez E, Bublevic J, Røe OD, Geitvik GAet al.(2024) Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1) ESMO Open, 9(6), 103475 DOI 10.1016/j.esmoop.2024.103475, PubMed 38838499